Filtros de búsqueda

Lista de obras de

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

artículo científico publicado en 2009

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

article

C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

artículo científico publicado en 2016

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

artículo científico publicado en 2017

Discovery of common and rare genetic risk variants for colorectal cancer

artículo científico publicado en 2018

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

artículo científico publicado en 2017

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

article

Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm

article

Impact of colonoscopic screening in Familial Colorectal Cancer Type X

artículo científico publicado en 2018

Meta-analysis of 16 studies of the association of alcohol with colorectal cancer

artículo científico publicado en 2019

Meta-analysis of new genome-wide association studies of colorectal cancer risk

artículo científico publicado en 2011

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

artículo científico publicado en 2019

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

article

Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.

artículo científico publicado en 2015

Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease

article

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

scientific article published on 19 December 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda